REGISTER RECORD · clinicaltrials.gov

NCT03332797

A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer

AS THE REGISTER RECORDS IT

Status and dates

Status as listedACTIVE_NOT_RECRUITING: running, but no longer enrolling
Register last updated2026-08-13
Retrieved by this site2026-08-31
Sourcehttps://clinicaltrials.gov/study/NCT03332797

What this record shows

This entry describes research activity. It is not a statement about market authorisation, and it is not regulatory, legal or medical advice: a trial being listed, completed or halted says nothing about whether a substance may be sold or used anywhere. Status wording is reproduced as the register writes it and is never mapped onto a simpler vocabulary.

All records · Method

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.